EVENT: UCI’s Sue & Bill Gross Stem Cell Research Center and the Center for Biotechnology and Global Health Policy have partnered to host a panel of experts discussing COVID-19. Four experts will address four topics related to the COVID-19 pandemic in everyday terms for the non-scientific community. As society begins to reopen, these four topics will drive how the population can stay informed and begin to resume activities safely. Questions during the live event are welcome.
WHEN/WHERE: May 14, from 7 to 8 p.m.
It will be streamed on Facebook at facebook.com/UCIStemCell and on YouTube at https://youtu.be/Pau-eWPE0RY.
Advance registration recommended.
The video will be available on demand after the live event via YouTube.
INFORMATION: The panelists are:
- Ming Tan, professor of medicine-infectious diseases and microbiology & molecular genetics, who will provide an introduction to SARS-CoV2/COVID-19
- Ed Monuki, professor and chair of pathology & laboratory medicine, who will discuss the current status of testing for COVID-19
- Michelle Goodwin, Chancellor’s Professor of law and director of the Center for Biotechnology & Global Health Policy, who will talk about the bioethics of reopening society
- Daniela Bota, UCI Alpha Stem Cell Clinic director & senior associate dean for clinical research, who will describe the COVID-19 clinical trial landscape
All of the UCI speakers are available for interviews based on their respective expertise.
BACKGROUND: The COVID-19 pandemic is the largest threat to global public health and the economy. The circumstances provide UCI the opportunity to assemble an expert cadre of healthcare professionals, scientists and scholars to take a deep dive into the “new normal” currently defined and what can be expected in its aftermath by COVID-19.
For UCI breaking news, visit news.uci.edu.